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Title: Understanding alcohol-related liver disease patients’ illness 
beliefs and views about their medicine. 
 
 INTRODUCTION  
Alcohol is believed to be a factor in 80% of cases of liver cirrhosis in the UK 
and carries a poorer prognosis than other causes (McCarron & Welter 2012, 
Thompson et al 2008). Alcohol-related liver disease (ALD) also makes a major 
contribution to a rise in hospital admissions and mortality rate (Neame & 
Hammond 2005). As a chronic condition, patients with ALD are often required 
to take diuretics and laxatives for the rest of their lives.  
These medications require constant monitoring and titrating of effect, carrying 
substantial side effects while often their intended effect may not be readily 
apparent. 30 – 50% of all patients do not take their treatment as prescribed, 
leading to a significantly increased risk of morbidity and mortality (Horne et al 
1999), and there is every reason to suspect that people with ALD are no 
exception. 
 
Horne et al (1999) argue that existing trials exploring medication non-
adherence lack underpinning theory. Usually they are only concerned with 
addressing unintentional factors, ignoring the motivation of the patient, and thus 
only addressing half of the problem. 
The nature of non-adherence is complex Gatti et al (2009). Horne describes 
the causes of non-adherence as being either intentional or unintentional, both 
of which need to be addressed to tackle the problem effectively. Unintentional 
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causes are largely beyond the patient’s control, but intentional non-adherence 
is a deliberate choice by the patient not to act, implying an issue of motivation.  
Gatti et al (2009) suggest that attitudes and beliefs about illness and medication 
strongly influence the likelihood of a patient adhering to their treatment. 
Research in this area is sparse. No research has been carried out on 
medication adherence and specifically patients with ALD. This paper is the first 
to explore their views about medicine and the relationship with their illness 
beliefs, socio-demographic factors and clinical data. The study findings can be 
used to develop tools to enhance medication adherence in patients with ALD. 
 
Psychological models have been developed to examine issues of individual 
motivation and health related behaviour, notably the Health Belief Model (HBM) 
(Becker 1974), the Theory of Planned Behaviour (TPB) (Ajzen 1985), Self-
efficacy (Bandura 1997) and the Self-regulatory Model of Illness (SRM) 
(Leventhal et al 1984). These models commonly identify patients’ illness beliefs 
as significant influences on health behavior changes. In the SRM, patients’ 
previous experience of illness is organized in a complex memory structure that 
is used to cluster and organize illness knowledge. Numerous research findings 
identifying illness representation components within the SRM framework 
(identity, cause, timeline, consequences and control/cure) as predictors of 
health outcomes. This has led to the creation of the Illness Perception 
Questionnarie (IPQ) (Weinman et al 1996) and later a short-form (BIPQ) 
(Broardbent 2006), used in this study. 
 
Research question 
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Is there an association between perceptions of illness symptoms (Illness belief 
component ‘identity’) and views of medication for patients with ALD? 
 
Study objectives  
1. To understand the views about medicines held by patients with ALD. 
2. To determine to what extent illness perception, self-reported alcohol intake and 
severity of disease influence patients’ views about their medicine.  
 
 
METHOD 
 
Design 
An observational cross sectional survey was carried out on patients with ALD 
who attended the Liver Outpatient Clinic at a London Hospital over a period of 
12 months (October 2012 to November 2013). They were invited to complete a 
set of validated instruments measuring illness beliefs and views about their 
medicine.  
 
Participants  
Inclusion Criteria 
- Patients with a confirmed primary diagnosis of ALD attending the outpatient 
clinic were eligible for the study.  
Exclusion criteria 
-Patients below 18 years of age 
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-Patients unable to understand and read English unaided which would affect 
their ability to participate in the study  
-Patients with severe cognitive impairment that prevented them from answering 
the questionnaires of the study even with assistance available. 
 
Data collection 
Patients were screened by an ALD Nurse Specialist and those who met criteria 
were invited to participate in the study. After gaining informed consent the 
participants completed a set of paper-based questionnaires. Additional data 
was acquired for demographics, body mass index (BMI) and Model of End-
stage Liver Disease (MELD) score.   
 
 
Measures 
All instruments used have proven validity and reliability. Wherever possible the 
short forms of these measures were selected to encourage participation. 
The following measures were used: 
 
Outcome variables 
Beliefs about Medicines Questionnaire (BMQ) (Horne & Weinman 1999) 
To assess patients’ views about their medicine, the BMQ consists of three 
components:  
 Necessity Score (NS) - five statements regarding how necessary 
patients consider their medication to be, measured using a 5-point 
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Likert scale with a score from 5 to 25. The higher score, the deeper the 
appreciation of the need for medication.  
 Concerns Score (CS) – five statements regarding how concerned 
patients are about the consequences of taking their medicine, 
measured as the NS. The higher score, the deeper the anxiety of the 
negative consequences of the medication. 
 A Necessity/Concern Differential (NCDiff) was calculated by subtracting the 
CS from the NS, ranging from -20 to +20. The more positive the score, the 
greater the tendency toward medication adherence, whilst a negative score 
will indicate a greater tendency toward non-adherence. 
Actual adherence to medication was not independently measured in this study as 
the primary concern was to assess motivations behind non-adherent acts. 
 
Explanatory variables 
Brief Illness Perception Questionnaire (BIPQ) (Broardbent 2006) 
Provides a quantitative assessment of the illness perception components 
described in Leventhal’s SRM [15]. The BIPQ consists of eight components 
measured on a zero to ten Likert scale: 
 Consequences - How much does your illness affect your life? 
 Timeline - How long do you think your illness will continue? 
 Personal control - How much control do you feel you have over your 
illness? 
 Treatment control - How much control do you think your treatment can 
help your illness? 
 Identity - How much do you experience symptoms from you illness? 
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 Concerns - How concerned are you about your illness? 
 Illness comprehension - How well do you feel you understand your 
illness? 
 Emotions- How much does your illness affect your emotionally? (e.g. 
does it make you angry, scared, upset or depressed?) 
 
The Alcohol Use Disorders Identification Test – Consumption (AUDIT-C) 
Three alcohol consumption questions used for the assessment of heavy 
drinking behaviors. A score of five or above is considered to be hazardous 
drinking Bradley et al 2007). 
 
The Model for End-Stage Liver Disease (MELD) score  
MELD score determines severity of chronic liver disease is used to predict 
mortality in patients awaiting transplant with a MELD of 20 generally being 
considered for transplantation (O’Grady et al).  
 
Demographic data and illness characteristics 
Gender, age, marital status, living arrangements, employment status, level of 
education, and ethnicity.  
Additional lifestyle information was body mass index (BMI), whether the 
patient is currently a smoker, and whether the patient has other chronic 
illnesses. 
This data was collected to allow for variable analysis adjustments. The study 
was not powered to determine whether they were independent factors in 
predicting adherence to medication. 
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Statistical Hypotheses 
1. The eight BIPQ components, MELD and AUDIT-C are not individually 
associated with NC, CS and NCDiff 
2. There is not a combined, or simultaneous, effect of the eight BIPQ components, 
MELD and AUDIT-C on NC, CS and NCDiff after adjusting for demographic and 
illness characteristic variables. 
 
Ethical considerations 
Ethical approval was obtained from the National Research Ethic Service 
Committee and the study was registered with the Research and Development 
Department at the hospital concerned.  
 
 
 
 
 
Data Analysis 
 
The strength of association between Necessity Score (NS), Concerns Score 
(CS) and Necessity/Concern Differential (NCDiff) and the eight Brief Illness 
Perception Questionnaire (BIPQ) components, Model for End-Stage Liver 
Disease (MELD) and Alcohol Use Disorders Identification Test – Consumption 
(AUDIT-C) were measured using Pearson’s correlation coefficient. 
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Three multiple regression models with outcome variables: NS, CS & NCDiff 
were regressed on the eight BIPQ components, MELD & AUDIT-C, adjusting 
for demographics and illness characteristics. 5% level of significance has been 
used throughout. 
 
 
 
RESULTS 
 
Demographic and illness characteristics 
159 completed the questionnaire pack. Age ranged from 27 to 80 (mean 52.3) 
and two thirds were male. 19% were single and 53% lived with someone. 
Eighty one percent were white; 66% were born in the United Kingdom. One 
quarter held a university degree. 26% reported being in employment or on 
sick leave, 26% unemployed and 19% retired. Thirty-nine percent had 
comorbidities (e.g. diabetes, COPD). BMI was unknown for 34% of patients, 
16% had a BMI ≥30 (obese) and BMI was <30 for 50%. Twenty nine percent 
reported being current smokers. Mean MELD and AUDIT-C Scores were 11.0 
(range 6-28) and 3.46 (range 0-12) respectively (Table 1). Based on AUDIT-C 
48% (n=71) of participants continued to drink alcohol of whom 56% (n=40) 
scored greater than 5. 
 
Table 1: Sample Characteristics (demographics and illness 
characteristics – MELD /AUDIT C) table 1. 
 
Demographics / 
Illness characteristics 
Frequencies (%*) / 
Mean (SD) Range 
Gender  
9 
 
   Male 
   Female 
   Unknown 
107 (69) 
48 (31) 
4  
Age*  
   <44 
45-54 
   >55 
   Unknown 
 
   Mean (SD) Range 
32 (23) 
50 (36) 
59 (41) 
18  
 
52 (11) 27-80 
Ethnic group  
   White 
   Other ethnic 
   groups/mixed 
   Unknown 
128 (84) 
25 (16) 
 
6 
Marital status  
   Single 
   Partner but not living 
   together 
   Married/living with 
   partner 
   Divorced/ separated/ 
   Widowed 
   Unknown 
30 (20) 
18 (13) 
 
68 (46) 
 
31 (21) 
 
12  
Living Arrangements  
   Lives alone 
   Lives with others 
   Unknown 
42 (30) 
99 (70) 
18  
Employment  
   Employed 
   On sick leave 
   Home maker 
   Retired  
   Not employed 
   Other 
   Unknown  
30 (21) 
11 (8) 
11 (8) 
30 (21) 
42 (29) 
19(13) 
16  
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Education  
   None 
   GCSE/ ‘O’ levels 
   ‘A’ levels 
   University degree 
   Other qualification 
   Other 
   Unknown 
29 (21) 
29 (21) 
15 (11) 
39 (28) 
16 (12) 
10 (7) 
21  
BMI  
   <18.5 
   <30 
   >31 
   Unknown 
    
   Mean (SD) Range  
6(6) 
79 (75) 
26 (25) 
54  
 
26.7 (5.5) 16.5-40.2 
Current smoker  
   Yes 
   No 
   Unknown 
46 (32) 
98 (68) 
15  
MELD score  
   Mean (SD) Range 11 (5) 6-28 
Total AUDIT-C score  
   >5 
   6< 
   Unknown 
 
   Mean (SD) Range 
92 (66) 
48 (34) 
19  
 
5 (5) 1-15 
 
Views about their medicine 
For the BMQ, NS was found to be higher than CS with means of 18.17(SD 
4.88) and 12.16 (SD 4.42) respectively and NCDiff was positive with a mean 
of 6.00 (SD 5.24) (Table 2). Thirteen participants (9%) had negative NCDiff 
scores. 
11 
 
Table 2: Illness belief and views about their medicine – summary statistics 
 
Explanatory variables n Mean SD Range 
Illness belief components:     
Consequences 159 5.77 3.03 0-10 
Timeline 152 7.74 2.80 0-10 
Personal control 158 3.99 2.90 0-10 
Treatment control 151 2.21 2.33 0-10 
Identity 158 5.32 3.04 0-10 
Concerns 157 7.42 2.92 0-10 
Illness Comprehension 157 2.15 2.41 0-10 
Emotions 157 5.50 3.32 0-10 
 
Outcome variables 
Views about their medicine: 
n Mean SD Range 
Necessity (NS) 142 18.17 4.88 5-25 
Concern (CS) 142 12.16 4.42 5-25 
Necessity-Concern difference (NCDiff) 142 6.00 5.24 -20 to +20 
 
Beliefs about their illness 
The illness belief component that produced the highest mean score was 
‘Timeline’, followed by ‘Concerns’ and ‘Consequences’ (Table 2). ‘Illness 
comprehension’ (2.15) had the lowest mean score followed by ‘Treatment 
control’ (2.21) and ‘Personal control’ (3.99). 
 
Association between Illness belief and views about their medicine   
 
Statistically significant association was found between NS and ‘identity’ (r=.40) 
and ‘Consequences’ (r=0.29),  whilst strong correlations were also found with 
‘Emotions’ (r=0.27) and ‘Illness concerns’ (r=0.26).  Statistically significant 
association was also found with CS and ‘identity’ (r=0.28), ‘Illness 
comprehension’ (r=0.35), ‘Emotions’ (r=0.33), ‘Treatment control’ (r=0.31) and 
‘Consequences’(r=0.29). NCDiff had a statistically significant association with  
‘Illness comprehension’(r=-0.21) and  ‘Treatment control’ (r=-0.20) (Table 2). 
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Correlations between NS, CS and NCDiff and MELD and AUDIT-C score were 
non-significant.  
 
 
Table 3: Associations (Pearson’s r) between illness perceptions, severity of 
chronic liver disease, alcohol use and beliefs about medicines. 
Explanatory variables: 
 
 Necessity 
Score 
(NS) 
Concerns 
Score (CS) 
Necessity-
Concerns 
differential 
(NCDiff) 
Illness beliefs components: 
Consequences (n=142) r 0.29 0.29 0.02 
p .001 <.001 .780 
Timeline (n=136) r 0.19 0.04 0.14 
p .030 .674 .097 
Personal control (n=142) r 0.14 0.22 -0.05 
p .089 .009 .551 
Treatment control (n=139) r 0.07 0.31 -0.20 
p .424 <.001 .021 
Identity (n=141) r 0.40 0.28 0.14 
p <.001 .001 .104 
Concerns (n=140) r 0.26 0.23 0.04 
p .002 .007 .599 
Illness comprehension (n=140) r 0.09 0.35 -0.21 
p .283 <.001 012 
Emotions (n=140) r 0.27 0.33 -0.03 
p .002 <0.001 .713 
Severity of chronic liver disease: 
MELD score (n=139) r 0.13 0.09 0.05 
p .122 .306 .569 
Alcohol use: 
AUDIT-C score (n=131) r -0.16 0.03 -0.18 
p .060 .692 .036 
 
 
 
 
 
DISCUSSION 
 
 
13 
 
Belief about medicine 
 
 
Patients in the Beliefs about Medicines Questionnaire (BMQ) survey scored a 
mean Necessity Score (NS) of 18.17 (Table 2) suggesting patient’s appreciated 
the importance of their drugs to their health and well-being, whereas the mean 
Concerns Score (CS) was lower at 12.16 (Table 2) indicating patients are less 
worried about having to take their medication. The higher NS and lower CS are 
reflected in the Necessity/Concern Differential (NCDiff) mean score being +6 
indicating patients are more strongly in agreement towards the necessity of 
their medication than towards concern. According to the health belief models 
(Health Belief Model, Becker 1974, and the Theory of Planned Behaviour, 
Ajzen 1985) in terms of a cost/benefit analysis, where beliefs held positively 
towards the benefit of taking medication, the patients’ behavioural intentions 
and actual behavior are biased towards taking medication as prescribed and 
as a result, intentional causes of non-adherence should be lessened. Almost 
one in ten participants had negative NCDiff scores, indicating their belief in the 
necessity for taking medication was outweighed by their concerns. Theory 
suggests these participants would be particularly prone to intentional non-
adherence. In the Pearson’s r analysis (Table 3), illness belief (IB) components 
‘Treatment control’, ‘Illness comprehension’ and ‘AUDIT-C’ were found to be 
significantly associated with NCDiff, suggesting patients’ who believe the 
treatment will control their illness, who understand their illness and who 
reported low alcohol intake are likely to adhere to their medication.  
 
Belief about Illness   
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Patients’ responses indicate that their illness has a strong impact on their life 
with high scores on illness belief components ‘Timeline’, ‘Concerns’ & 
‘Consequences’. Patients also do not feel they are in control of their illness 
and have little understanding of their illness. Importantly both IB components 
‘Treatment control’ and ‘Illness comprehension’ are the two key IB 
components that are associated with medication adherence. Lack of control 
has been the key element that predicts negative impact on intention and 
actual health behaviour change in a number of psychological theories such as 
TPB (Ajzen 1985) and Bandura’s self-efficacy (1997) and these results would 
suggest a higher inclination towards intentional non-adherence.  
 
In the multiple regression analyses, two of the illness beliefs components 
‘Identity’ and ‘Illness comprehension’ are significantly association with BMQ 
component NS and CS respectively. This suggests patients’ interpretation of 
the meaning of their illness is particularly associated with their medication 
adherence beliefs.   
 
Alcohol intake and adherence 
Almost a half of all participants reported that they continued to drink alcohol 
with over a half of these continue to consume hazardous amounts. General 
expectations that patients who continue to drink heavily (with a high AUDIT-C 
scores) might also hold beliefs that are consistent with non-adherence to 
medication regimes, as they are already non-adherent to one part of their 
treatment plan. The current study has shown that alcohol intake (AUDIT-C) has 
a weak association (r=0.18) with NCDiff (Table 3). This would support Horne et 
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al’s (1999) position that there is no such thing as a non-adherent patient in 
medicine, and that anyone can be susceptible to non-adherent behavior and 
can be both adherent and non-adherent simultaneously to different parts of the 
prescribed treatment. An effective intervention to address non-adherence must 
therefore be tailored to the individual patient and to the specific treatments 
concerned. 
 
Severity of illness and illness identity 
No association between medication beliefs and MELD score. Patients’ beliefs 
about their medicine were significantly more influenced by their experience of 
symptoms rather than by actual underlying severity.  
 
Findings suggest that patients who gave a high score to the question “How 
much do you experience symptoms of your illness?” also felt a greater sense 
of necessity for their medication. For ALD, acceptance of having the disease, 
is complicated as many sufferers may be virtually asymptomatic until the end 
stages. Additionally the label of “alcoholic” brings negative connotations that 
can be difficult for patients to identify with. Blaxter and Cyster (1948) identify 
that some patients struggle to accept that they consume no more, or even less, 
than others who do not have ALD.  
 
Illness Comprehension and education background 
The IB component ‘Illness comprehension’ was significantly associated with 
CS, suggesting that the more the patient understands their illness, the less they 
feel concerned about the negative effects of their medication. Conversely, with 
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greater understanding, the cost side of the behavioural evaluation, which takes 
place in the HBM, is reduced. Theory suggests this would make adherence to 
medication more likely. Educational background was not found to be associated 
with any of the BMQ components in this survey and suggests that prior 
education is not a prerequisite to perceived illness comprehension.  
 
The significant association between views held by patients with ALD about their 
medicine and the two IB components ‘identity’ and ‘comprehension’ would 
suggest that to address medication adherence in this patient group it is 
important to address the individual’s perception of their illness symptoms and 
their understanding of their health condition.  
 
LIMITATIONS OF STUDY 
As with all cross-sectional survey design, we are not able to establish the 
direction of the relationship between variables, only associations between the 
BMQ components and BIPQ components. Also, due to resource limitations, we 
collected a convenience sample and were not able to a follow-up this survey 
with a longitudinal approach.  
 
CONCLUSION  
Positive beliefs about medication held by patients with ALD were associated 
with greater sense of illness identity and comprehension. It would follow that 
future research should focus on patient assessment tools and tailored 
educational interventions designed to promote these two dimensions of illness 
representation. 
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